Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years 1

By Patard J.-J.   Moudouni S.   Saint F.   Rioux-Leclercq N.   Manunta A.   Guy L.   Ballanger P.   Lanson Y.   Hajri M.   Irani J.   Guille F.   Beurton D.   Lobel B.   The members of the Groupe Necker  

Urology, Vol. 58, Iss. 4, 2001-10 ,pp. : 551-556

Elsevier

Access to resources Recommend Favorite

Prognostic value of p53, Ki-67, microstaging and microvessel density in pT1G3 bladder tumors: Creation of risk groups for progression

By Queipo-Zaragoza José Antonio   Ruiz-Cerda José Luíz   Vera-Donoso Cesar David   Vera-Sempere Francisco   Budia-Alba Alberto   Jimenez-Cruz Juan Fernando  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 4, 2007-09 ,pp. : 283-289

Informa Healthcare

Access to resources Recommend Favorite

G protein beta 3 subunit C825T polymorphism and disease progression in patients with bladder cancer

By Lummen G.   Eisenhardt A.   Rosskopf D.   Rubben H.   Siffert W.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 42-42

Elsevier

Access to resources Recommend Favorite

Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guerin therapy

By Peyromaure M.   Weibing S.   Sebe P.   Verpillat P.   Toublanc M.   Dauge M.-C.   Boccon-Gibod L.   Ravery V.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 409-413

Elsevier

Access to resources Recommend Favorite

Intravesical Bacillus Calmette-Guerin Treatment Improves Patient Survival in T1G3 Bladder Tumours

By Patard J.-J.   Rodriguez A.   Leray E.   Rioux-Leclercq N.   Guille F.   Lobel B.  

European Urology, Vol. 41, Iss. 6, 2002-06 ,pp. : 635-642

Elsevier

Access to resources Recommend Favorite